US Food and Drug Administration: The overall benefits of Novartis and Atvis's approved indications continue to outweigh their potential risks.

Zhitongcaijing · 2d ago
US Food and Drug Administration: The overall benefits of Novartis and Atvis's approved indications continue to outweigh their potential risks.